EASL Studio - Special Edition - Live from the Liver Cancer Summit 2022

The highlights of EASL’s Liver Cancer Summit 2022 – What is practice changing right now and where are the current controversies?

How do our experts interpret the new data on Immunotherapy in HCC and CCA, and what to expect in 2022: upcoming trials, new combinations, new biomarkers.

#livercancer #HCC

Find out more on: https://easl.eu/easl-studio/